Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-07-17
1994-12-20
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 514 46, 514 49, 536 221, A01N 4304, A61K 3170, C07H 1900
Patent
active
053746252
ABSTRACT:
A novel nucleic acid derivative represented by the following general formula (I) and physiologically acceptable salt thereof which are expected to have an antiviral activity: ##STR1## wherein B represents a nucleic acid base derivative; A.sup.1 and A.sup.2 represent, independently of each other, OR.sup.1 or OCOR.sup.1 ; R.sup.1 represents a hydrogen atom, a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group; l represents a number of 0 or 1; and m and n each represents an integer of 0-2; provided that when l and m are 0, n is 0 or 2.
REFERENCES:
patent: 4383114 (1983-05-01), Vince
patent: 4988703 (1991-01-01), Norbeck et al.
The Journal of Antibiotics, vol. XLII, No. 4, 1989 pp. 644-646.
Antimicrobial Agents and Chemotherapy, vol. 32, No. 7, 1988, pp. 1053-1056.
Medical Research Review vol. 6, No. 1, pp. 1-40 (1986).
Journal of the Chemical Society, Chemical Communications, No. 24: 1989, pp. 1919-1921; Ichikawa et al., "Enantio- and Diastereo-Selective Synthesis of Carbocyclic . . . ".
The Journal of Antibiotics, vol. XLII, No. 12, Dec. 1989, pp. 1854-1859; Nishiyama et al.: "Anti-Herpes Virus Activity of Carbocyclic Oxetanocin . . . ".
Chemical and Pharmaceutical Bulletin, vol. 38, No. 1, Jan. 1990, pp. 288-290. Katagiri et al.: "Highly Stereoselective Synthesis of Carbocyclic Analogues . . . ".
Akaba Hiroshi
Hoshino Hiroo
Ichikawa Yuh-ichiro
Matsubara Kenichi
Nagahata Takemitsu
Crouch Deborah
Nippon Kayaku Kabushiki Kaisha
Weimar Elizabeth C.
LandOfFree
Adenine and guanine derivatives for the treatment of hepatitis v does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenine and guanine derivatives for the treatment of hepatitis v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenine and guanine derivatives for the treatment of hepatitis v will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2386323